Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05558241 · ClinicalTrials.gov registry record · NA

Micro-UltraSound In Cancer - Active Surveillance

A NA study of Prostate Cancer, sponsored by University of Alberta.

Recruiting
Registry status
NA
Development phase
210
Enrollment target
5
Study locations

NCT05558241 is a NA study of Prostate Cancer that is actively recruiting participants, run by University of Alberta. The registered enrollment target is 210 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (65% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05558241, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by University of Alberta.

RECRUITING
Registry status
NA
Development phase
210 participants
Enrollment target
5
Study locations

Study Summary

This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores. The primary goal is to compare microUS to MRI for the detection of ≥GG2 PCa at confirmatory biopsy. This study will also collect blood samples from participants to be used for future biomarker studies.

Conditions Studied

Interventions

  • DEVICE High-resolution micro-ultrasound

Study Locations (5)

Alberta

  • Kipnes Urology Centre - Kaye Edmonton Clinic - Edmonton
  • University of British Columbia - Vancouver

California

  • University of California Los Angeles, Department of Urology - Los Angeles

Quebec

  • CIUSSS du Nord-de-L'Ile-De-Montreal - Montreal

Other

  • Humanitas - Milan

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2022-11-30
Est. Completion 2033-06-30
Phase NA

Sponsor

University of Alberta

19 total trials

What the Registry Record Tells You About NCT05558241

The ClinicalTrials.gov registry entry for NCT05558241 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (65% lower). The listed sponsor is University of Alberta, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which High-resolution micro-ultrasound is the first listed.

NCT05558241 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Alberta, California, Quebec.

Frequently Asked Questions

What is clinical trial NCT05558241 about?

NCT05558241 is a clinical study titled "Micro-UltraSound In Cancer - Active Surveillance". This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, fi...

What is the current status of trial NCT05558241?

This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2022-11-30. Estimated completion is 2033-06-30.

What conditions does trial NCT05558241 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05558241?

The interventions under investigation include: High-resolution micro-ultrasound (DEVICE).

Who is sponsoring clinical trial NCT05558241?

This trial is sponsored by University of Alberta, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05558241 being conducted?

This trial has 5 study locations across California, Alberta, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.